Chi Dong-sheng, Ling Wen-hua, Ma Jing, Xia Min, Hou Meng-jun, Wang Qing, Zhu Hui-lian, Tang Zhi-hong, Yu Xiao-ping
Faculty of Medical Nutriology, College of Public Health, Sun Yat-sen University, Guangzhou, Guangdong, 510080 PR China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Jun;23(3):289-93.
To study the relationships between paraoxonase 1 55 Met/Leu (PON1 55Met/Leu), paraoxonase 2 148 Ala/Gly(PON2 148Ala/Gly) genetic polymorphisms and coronary artery disease(CAD), plasma activities of paraoxonase (PON), total superoxide dismutase (T-SOD), as well as plasma concentration of maleic dialdehyde (MDA).
The PCR-RFLP method was applied to identify the genetic polymorphisms of PON1 55Met/Leu and PON2 148Ala/Gly, and the colorimetry way was used to detect plasma activities of PON, T-SOD and plasma MDA concentration of 262 CAD patients and 100 controls.
Comparing with control, the CAD patient had the obviously lower activities of enzymes PON (349.27+/- 138.36 nmol/min.mL vs 454.75+/- 166.00 nmol/min.mL, P< 0.001) and T-SOD (23.61+/- 16.51 U/mL vs 44.01+/- 22.68 U/mL, P< 0.001) while getting the plasma MDA concentration increased markedly(2.47+/- 0.73 nmol/mL vs2.15+/- 0.55 nmol/mL, P< 0.01). The CAD patient had more LM genotype and M allele of PON1 55Met/Leu(24.8% vs 1.4%, P< 0.001 and 12.4% vs 0.5%, P was 0.001 respectively), GG and AG genotype and G allele of PON2 148 Ala/Gly(11.8% vs 5.0%, P< 0.001; 48.1% vs 24.0%, P< 0.001 and 36.0% vs 17.0%, P< 0.001 respectively) than control did. The activities of plasma PON and T-SOD were lower in individuals with PON??1 55 LM genotype than those with LL genotype(304.73+/- 125.04 vs 394.84+/- 154.87 nmol/min.mL and 24.89+/- 16.14 vs 30.22+/- 21.29 U/mL, P< 0.001 and P< 0.05 respectively). The activity of plasma PON was also lower in individuals with PON2 148 GG/AG genotype than that with AA genotype(281.47+/- 84.70 vs 356.00+/- 145.95 vs 417.34+/- 159.00 nmol/min.mL, P< 0.001). Logistic regression analysis showed that PON1 55 LM genotype (OR 29.08, 95%CI 2.88-294.04, P was 0.004) and M allele(OR 15.17, 95%CI 1.32-174.29, P was 0.029), PON2 148 GG/AG genotype (OR 2.32, 95%CI 1.52-3.54, P< 0. 001) and G allele (OR 3.24, 95%CI 1.38-7.61, P was 0.007) were independent risk factors for CAD.
The CAD patient has the obviously low activities of plasma PON and T-SOD but on the contrary, get the plasma MDA concentration increased markedly. PON1 55 LM genotype and M allele, PON2 148 GG/AG genotype and G allele are the risk factors for coronary artery disease, and the activity of plasma PON is also markedly reduced in individuals with above genotypes.
研究对氧磷酶1 55位甲硫氨酸/亮氨酸(PON1 55Met/Leu)、对氧磷酶2 148位丙氨酸/甘氨酸(PON2 148Ala/Gly)基因多态性与冠状动脉疾病(CAD)、对氧磷酶(PON)血浆活性、总超氧化物歧化酶(T-SOD)以及血浆丙二醛(MDA)浓度之间的关系。
采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法鉴定PON1 55Met/Leu和PON2 148Ala/Gly的基因多态性,采用比色法检测262例CAD患者和100例对照者的PON、T-SOD血浆活性及血浆MDA浓度。
与对照组相比,CAD患者的PON(349.27±138.36 nmol/min·mL对454.75±166.00 nmol/min·mL,P<0.001)和T-SOD(23.61±16.51 U/mL对44.01±22.68 U/mL,P<0.001)血浆活性明显降低,而血浆MDA浓度显著升高(2.47±0.73 nmol/mL对2.15±0.55 nmol/mL,P<0.01)。CAD患者的PON1 55Met/Leu的LM基因型和M等位基因(24.8%对1.4%,P<0.001;12.4%对0.5%,P分别为0.001)、PON2 148Ala/Gly的GG和AG基因型及G等位基因(11.8%对5.0%,P<0.001;48.1%对24.0%,P<0.001;36.0%对17.0%,P<0.001)均高于对照组。PON1 55 LM基因型个体的血浆PON和T-SOD活性低于LL基因型个体(304.73±125.04对394.84±154.87 nmol/min·mL和24.89±16.14对30.22±21.29 U/mL,P<0.001和P<0.05)。PON2 148 GG/AG基因型个体的血浆PON活性也低于AA基因型个体(281.47±84.70对356.00±145.95对417.34±159.00 nmol/min·mL,P<0.001)。Logistic回归分析显示,PON1 55 LM基因型(比值比29.08,95%可信区间2.88-294.04,P=0.004)和M等位基因(比值比15.17,95%可信区间1.32-174.29,P=